28Jul 2023
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)

The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)

Haemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) can rapidly progress, leading to organ failure and death. A task force of global experts developed evidence-based points to assist clinicians in early diagnosis, treatment, and monitoring. The guidelines emphasize prompt syndrome recognition, systematic evaluation of underlying causes, early intervention to target hyperinflammation, and multidisciplinary support.

  • #rheumatology

Like

Save

Share